Vireo Growth Inc. logo

Vireo Growth Inc. (VREO)

Market Closed
3 Jun, 19:37
CNSX CNSX
CA$
0. 5700
-0.01
-1.72%
CA$
- Market Cap
- P/E Ratio
- Div Yield
98,900 Volume
- Eps
CA$ 0.58
Previous Close
Add Transaction
Day Range
0.55 0.57
Year Range
0.455 1.08
Want to track VREO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming VREOF split of 1:30 in 1 days (5 Jun 2026)

Summary

VREO closed today lower at CA$0.57, a decrease of -1.72% from yesterday's close, completing a monthly decrease of -5% or -CA$0.03. Over the past 12 months, VREO stock lost -32.94%.
VREO is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2026, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.02%, based on the last three reports.
Vireo Growth Inc. has a scheduled stock split on Jun 05, 2026 for a 1:30 split ratio, meaning every VREO investor will receive 1.0 shares for every 30.0 existing shares.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on OTCQX (USD).

VREO Chart

Vireo Growth Inc. (VREOF) Q1 2026 Earnings Call Transcript

Vireo Growth Inc. (VREOF) Q1 2026 Earnings Call Transcript

Vireo Growth Inc. (VREOF) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Vireo Growth Inc. (VREOF) Q4 2025 Earnings Call Transcript

Vireo Growth Inc. (VREOF) Q4 2025 Earnings Call Transcript

Vireo Growth Inc. (VREOF) Q4 2025 Earnings Call Transcript

Seekingalpha | 2 months ago
Vireo Growth Inc. (VREOF) Q3 2025 Earnings Call Transcript

Vireo Growth Inc. (VREOF) Q3 2025 Earnings Call Transcript

Vireo Growth Inc. (OTCQX:VREOF) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants John Mazarakis - CEO & Co-Executive Chairman Tyson Macdonald - Chief Financial Officer Conference Call Participants Michael Kim - Zacks Small-Cap Research Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning, and welcome to the Vireo Growth Inc. Third Quarter 2025 Results Call. The company would like to remind everyone that today's conference call may contain forward-looking statements within the meaning of U.S. and Canadian securities laws.

Seekingalpha | 6 months ago

Vireo Growth Inc. (VREO) FAQ

What is the stock price today?

The current price is CA$0.5700.

On which exchange is it traded?

Vireo Growth Inc. is listed on CNSX.

What is its stock symbol?

The ticker symbol is VREO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Vireo Growth Inc. ever had a stock split?

No, there has never been a stock split.

Vireo Growth Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
John Michael Mazarakis CEO
CNSX Exchange
CA92767B1058 ISIN
US Country
419 Employees
- Last Dividend
5 Jun 2026 Last Split
- IPO Date

Overview

Vireo Growth Inc. is a dynamic entity in the cannabis industry within the United States, focusing on the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products. Formerly known as Goodness Growth Holdings, Inc., the company underwent rebranding to Vireo Growth Inc. in July 2024, aligning its corporate identity with its expansion and broadening vision. Based in Minneapolis, Minnesota, Vireo Growth makes its mark by offering a wide array of cannabis products, catering to both medical patients and recreational consumers across Maryland, Minnesota, and New York through its Green Goods and other Goodness Growth branded retail dispensaries, as well as through third-party dispensaries. The strategic positioning of its operations underscores the company's commitment to quality, innovation, and accessibility in the burgeoning cannabis market.

Products and Services

  • Medical Cannabis Products
  • These products focus on fulfilling the needs of patients with various health conditions. Utilizing advanced cultivation and manufacturing processes, Vireo Growth Inc. produces a diverse range of medical cannabis products, including but not limited to, tinctures, capsules, and vaporizable oils. These products are designed for patients seeking relief from specific medical conditions, ensuring they receive the therapeutic benefits of cannabis with consistent quality and efficacy.

  • Adult-Use Cannabis Products
  • Targeted at the recreational market, adult-use cannabis products by Vireo Growth cater to consumers looking for premium cannabis experiences. The range includes a variety of forms such as flowers, pre-rolled joints, edibles, and concentrates, providing a broad spectrum of options for recreational use. By prioritizing safety, purity, and potency, these products aim to meet the diverse preferences and tastes of adult consumers.

  • Retail Distribution Network
  • Vireo Growth expands its reach and accessibility through a strategic network of retail dispensaries, including Green Goods and other Goodness Growth branded stores, along with third-party dispensaries. This extensive distribution network ensures that both medical and recreational consumers have convenient access to their wide range of cannabis products, regardless of their location in Maryland, Minnesota, and New York. By offering an inviting in-store experience and knowledgeable staff, Vireo Growth aims to educate customers, while providing a safe and welcoming environment for purchasing cannabis products.

Contact Information

Address: 207 South 9th Street
Phone: 612 999 1606